NO20080125L - 2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament - Google Patents

2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament

Info

Publication number: NO20080125L
Authority: NO; Norway
Prior art keywords: processes; preparation; medicament; quinolinyl derivatives; diseases including
Prior art date: 2005-06-09

Application number

NO20080125A

Other languages

English (en)

Norwegian (no)

Inventor

Benjamin Perry

Original Assignee

Ucb Pharma Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-06-09

Filing date

2008-01-08

Publication date

2008-01-08

2005-06-09 Priority claimed from GB0511781A external-priority patent/GB0511781D0/en

2006-01-06 Priority claimed from GB0600213A external-priority patent/GB0600213D0/en

2008-01-08 Application filed by Ucb Pharma Sa filed Critical Ucb Pharma Sa

2008-01-08 Publication of NO20080125L publication Critical patent/NO20080125L/no

Links

238000000034 method Methods 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
239000003814 drug Substances 0.000 title 1
201000004624 Dermatitis Diseases 0.000 abstract 3
208000011231 Crohn disease Diseases 0.000 abstract 2
201000001320 Atherosclerosis Diseases 0.000 abstract 1
206010010741 Conjunctivitis Diseases 0.000 abstract 1
208000004262 Food Hypersensitivity Diseases 0.000 abstract 1
206010016946 Food allergy Diseases 0.000 abstract 1
208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
208000003251 Pruritus Diseases 0.000 abstract 1
201000004681 Psoriasis Diseases 0.000 abstract 1
206010039085 Rhinitis allergic Diseases 0.000 abstract 1
208000024780 Urticaria Diseases 0.000 abstract 1
201000010105 allergic rhinitis Diseases 0.000 abstract 1
208000006673 asthma Diseases 0.000 abstract 1
208000010668 atopic eczema Diseases 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
235000020932 food allergy Nutrition 0.000 abstract 1
239000008177 pharmaceutical agent Substances 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
201000009890 sinusitis Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Dermatology (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Hematology (AREA)
Oncology (AREA)
Heart & Thoracic Surgery (AREA)
Ophthalmology & Optometry (AREA)
Urology & Nephrology (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Transplantation (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Vascular Medicine (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

NO20080125A 2005-06-09 2008-01-08 2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament NO20080125L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0511781A GB0511781D0 (en)	2005-06-09	2005-06-09	2,6-quinolinyl derivatives, processes for preparing them and their uses
US20615805A	2005-08-18	2005-08-18
GB0600213A GB0600213D0 (en)	2006-01-06	2006-01-06	2,6-quinolinyl derivatives, processes for preparing them and their uses
PCT/EP2006/004811 WO2006131200A1 (en)	2005-06-09	2006-05-22	2,6 quinolinyl derivatives, processes for preparing them and their use as medicament

Publications (1)

Publication Number	Publication Date
NO20080125L true NO20080125L (no)	2008-01-08

Family

ID=36968449

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20080125A NO20080125L (no)	2005-06-09	2008-01-08	2,6-kinolinylderivater, fremgangsmater for fremstilling derav og deres anvendelse som medikament

Country Status (19)

Country	Link
US (1)	US7732614B2 (de)
EP (1)	EP1902045B1 (de)
JP (1)	JP2008542407A (de)
KR (1)	KR20080021085A (de)
AR (1)	AR054129A1 (de)
AT (1)	ATE496041T1 (de)
AU (1)	AU2006254772B2 (de)
BR (1)	BRPI0611243A2 (de)
CA (1)	CA2610800A1 (de)
DE (1)	DE602006019731D1 (de)
EA (1)	EA013080B1 (de)
IL (1)	IL187235A0 (de)
MX (1)	MX2007014721A (de)
MY (1)	MY140739A (de)
NO (1)	NO20080125L (de)
NZ (1)	NZ563739A (de)
PE (1)	PE20070081A1 (de)
TW (1)	TW200716605A (de)
WO (1)	WO2006131200A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101200450A (zh)	2002-04-30	2008-06-18	Ucb公司	2,6-喹啉基和2,6-萘基衍生物、用于制备它们的方法和它们作为vla-4抑制剂的用途
CA2478458A1 (en) *	2004-08-20	2006-02-20	Michael Panzara	Treatment of pediatric multiple sclerosis
JP2008520717A (ja) *	2004-11-19	2008-06-19	バイオジェン・アイデック・エムエイ・インコーポレイテッド	多発性硬化症についての処置
DE602006019731D1 (de)	2005-06-09	2011-03-03	Ucb Pharma Sa	2,6-chinolinderivate sowie verfahren zu ihrer herstellung und verwendung als arzneimittel
WO2008125215A1 (en) *	2007-04-12	2008-10-23	Ucb Pharma, S.A.	Bicyclic and heterobicyclic derivatives, processes for preparing them and their uses
WO2010121141A1 (en) *	2009-04-17	2010-10-21	Biogen Idec Ma Inc.	Compositions and methods to treat acute myelogenous leukemia
EA201291065A1 (ru)	2010-04-16	2013-03-29	Байоджен Айдек Ма Инк.	Антитела против vla-4
MY160723A (en) *	2013-12-30	2017-03-15	Univ Putra Malaysia	An anticoagulant
USD812958S1 (en)	2016-06-08	2018-03-20	Samsung Electronics Co., Ltd.	Cooktop
US20200087390A1 (en)	2016-12-21	2020-03-19	Amgen Inc.	Anti-tnf alpha antibody formulations
CN112312910A (zh)	2018-04-12	2021-02-02	莫菲克医疗股份有限公司	人整合素α4β7拮抗剂
JP7457661B2 (ja)	2018-06-04	2024-03-28	バイオジェン・エムエイ・インコーポレイテッド	低減したエフェクター機能を有する抗ｖｌａ－４抗体
KR102630416B1 (ko)	2018-10-30	2024-02-01	길리애드 사이언시즈, 인코포레이티드	알파4베타7 인테그린 억제제로서의 퀴놀린 유도체
AU2019373242B2 (en) *	2018-10-30	2023-07-13	Gilead Sciences, Inc.	Compounds for inhibition of alpha 4 beta 7 integrin
ES3013256T3 (en)	2018-10-30	2025-04-11	Gilead Sciences Inc	Imidazo[1,2-a]pyridine derivatives as alpha4beta7 integrin inhibitors for the treatment of inflammatory diseases
US11179383B2 (en) *	2018-10-30	2021-11-23	Gilead Sciences, Inc.	Compounds for inhibition of α4β7 integrin
CN114222730B (zh)	2019-08-14	2024-09-10	吉利德科学公司	用于抑制α4β7整合素的化合物
AU2020366435A1 (en)	2019-10-16	2022-04-21	Morphic Therapeutic, Inc.	Inhibiting human integrin α4β7
WO2025106410A1 (en) *	2023-11-15	2025-05-22	Dice Molecules Sv, Inc.	Alpha 4 beta 7 integrin modulators and uses thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0798291B1 (de)	1994-12-14	2002-09-11	Santen Pharmaceutical Co., Ltd.	Neue 1,3-dialkylharnstoff-derivate
ATE267801T1 (de)	1997-08-22	2004-06-15	Hoffmann La Roche	N-alkanoylphenylalaninderivate
SK2612001A3 (en)	1998-08-26	2001-11-06	Aventis Pharma Ltd	Aza-bicycles which modulate the inhibition of cell adhesion
JP2002543194A (ja)	1999-04-28	2002-12-17	ドクター・レディーズ・ラボラトリーズ・リミテッド	置換二環系ヘテロ環化合物、その製造方法、並びに抗肥満症及び抗高コレステロール血症剤としてのこれらの使用
MY129000A (en)	2000-08-31	2007-03-30	Tanabe Seiyaku Co	INHIBITORS OF a4 MEDIATED CELL ADHESION
MY140707A (en)	2002-02-28	2010-01-15	Mitsubishi Tanabe Pharma Corp	Process for preparing a phenylalanine derivative and intermediates thereof
CN101200450A (zh) *	2002-04-30	2008-06-18	Ucb公司	2,6-喹啉基和2,6-萘基衍生物、用于制备它们的方法和它们作为vla-4抑制剂的用途
US7153870B2 (en) *	2003-07-25	2006-12-26	Pfizer Inc.	Nicotinamide derivatives useful as PDE4 inhibitors
GB0329584D0 (en)	2003-12-20	2004-01-28	Tanabe Seiyaku Co	Novel compounds
DE602006019731D1 (de)	2005-06-09	2011-03-03	Ucb Pharma Sa	2,6-chinolinderivate sowie verfahren zu ihrer herstellung und verwendung als arzneimittel

2006
- 2006-05-22 DE DE602006019731T patent/DE602006019731D1/de not_active Expired - Lifetime
- 2006-05-22 KR KR1020077031009A patent/KR20080021085A/ko not_active Withdrawn
- 2006-05-22 CA CA002610800A patent/CA2610800A1/en not_active Abandoned
- 2006-05-22 AR ARP060102077A patent/AR054129A1/es not_active Application Discontinuation
- 2006-05-22 BR BRPI0611243-9A patent/BRPI0611243A2/pt not_active IP Right Cessation
- 2006-05-22 MX MX2007014721A patent/MX2007014721A/es active IP Right Grant
- 2006-05-22 MY MYPI20062356A patent/MY140739A/en unknown
- 2006-05-22 AT AT06753758T patent/ATE496041T1/de not_active IP Right Cessation
- 2006-05-22 JP JP2008515081A patent/JP2008542407A/ja active Pending
- 2006-05-22 AU AU2006254772A patent/AU2006254772B2/en not_active Ceased
- 2006-05-22 EA EA200702589A patent/EA013080B1/ru not_active IP Right Cessation
- 2006-05-22 NZ NZ563739A patent/NZ563739A/en not_active IP Right Cessation
- 2006-05-22 EP EP06753758A patent/EP1902045B1/de not_active Expired - Lifetime
- 2006-05-22 WO PCT/EP2006/004811 patent/WO2006131200A1/en not_active Ceased
- 2006-06-02 PE PE2006000596A patent/PE20070081A1/es not_active Application Discontinuation
- 2006-06-05 TW TW095119798A patent/TW200716605A/zh unknown
- 2006-06-09 US US11/450,694 patent/US7732614B2/en not_active Expired - Fee Related
2007
- 2007-11-08 IL IL187235A patent/IL187235A0/en unknown
2008
- 2008-01-08 NO NO20080125A patent/NO20080125L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP2008542407A (ja)	2008-11-27
CA2610800A1 (en)	2006-12-14
TW200716605A (en)	2007-05-01
KR20080021085A (ko)	2008-03-06
US7732614B2 (en)	2010-06-08
AU2006254772B2 (en)	2011-06-02
AR054129A1 (es)	2007-06-06
EP1902045B1 (de)	2011-01-19
WO2006131200A1 (en)	2006-12-14
PE20070081A1 (es)	2007-02-15
NZ563739A (en)	2009-12-24
EA200702589A1 (ru)	2008-06-30
DE602006019731D1 (de)	2011-03-03
EP1902045A1 (de)	2008-03-26
BRPI0611243A2 (pt)	2010-08-24
EA013080B1 (ru)	2010-02-26
MY140739A (en)	2010-01-15
US20070004775A1 (en)	2007-01-04
MX2007014721A (es)	2008-02-14
AU2006254772A1 (en)	2006-12-14
IL187235A0 (en)	2008-02-09
ATE496041T1 (de)	2011-02-15

Legal Events

Date	Code	Title	Description
2011-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
SG155943A1 (en)	2009-10-29	Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
NO20045234L (no)	2005-01-18	2,6-kinolinyl- og 2,6-naftylderivater, fremgangsmate for fremstilling av disse, og anvendelse av disse som VLA-4-inhibitorer
ME01515B (me)	2014-04-20	PIRIMIDINSKI DERIVATI ZA TRETMAN ASTME, HOBP, ALERGIJSKOG RINITISA, ALERGIJSKOG KONJUNKTIVITISA, ATOPIČNOG DERMATITISA, RAKA, HEPATITISA B, HEPATITISA C, HIV-a, HPV-a, BAKTERIJSKIH INFEKCIJA I DERMATOZE
HRP20050318A2 (en)	2006-07-31	Pyrimidinone derivatives as therapeutic agents against acute and chronic inflamatory, ischaemic and remodelling processes
NO20083427L (no)	2008-10-14	Cystoksiske midler omfattende nye tomaymycinderivater og deres terapeutiske anvendelse
ATE479678T1 (de)	2010-09-15	Benzoimidazol-2-yl pyridine als modulatoren des histamin-h4-rezeptors
NO20083919L (no)	2008-12-19	Pyridin- og pyrimidinderivater som mGluR2-antagonister
ATE457311T1 (de)	2010-02-15	Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
PH12013502445A1 (en)	2014-01-20	Pyridin-2 (1h) -one derivatives useful as medicaments for the treatment of myeloproliferative disorders, transplant rejection, immune-mediated and inflammatory diseases
NO20052076L (no)	2005-04-27	Fuserte azol-pyrimidinderivater.
WO2005021515A3 (en)	2005-08-25	Inhibitors of phosphodiesterase type-iv
NO20090268L (no)	2009-03-06	Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor
NO20083358L (no)	2008-09-30	Piperasinyl derivater som modulatorer for kjemokine reseptor aktivitet
MX2009002171A (es)	2009-05-28	Derivados de triazol como inhibidores de cinasas.
NZ595152A (en)	2013-04-26	Nematocidal sulfonamides
HRP20050532A2 (en)	2006-09-30	Novel fluoroglycoside heterocyclic derivatives, pharmaceutical products containing said compounds and the use thereof
SG155909A1 (en)	2009-10-29	Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors
MX2007008924A (es)	2007-08-21	Compuestos quimicos.
BR112013005622A2 (pt)	2016-05-03	heteroaril metil amidas
NO20084411L (no)	2008-11-03	Tetrahydro-pyrimidoazepiner som modulatorer av TRPVI
NO20076682L (no)	2008-03-05	Nye pyridinanaloger
EA200900472A1 (ru)	2009-10-30	Ингибиторы фосфодиэстеразы iv типа
NO20082054L (no)	2008-06-02	Nye 2-fenylimidazo[4,5-b]pyridinderivater som inhibitorer av glykogensyntasekinase for behandling av demens og neurodegenerative forstyrrelser
ATE542795T1 (de)	2012-02-15	Benzylpiperazinderivate als motilin- rezeptorantagonisten
NO20074780L (no)	2007-11-01	Heterocyklylamidsubstituerte imidazoler